enVVeno Medical Corporati... (NVNO)
NASDAQ: NVNO
· Real-Time Price · USD
3.68
0.05 (1.38%)
At close: May 09, 2025, 10:42 AM
1.38% (1D)
| Bid | 3.6 |
| Market Cap | 64.51M |
| Revenue (ttm) | 812K |
| Net Income (ttm) | -21.33M |
| EPS (ttm) | -1.18 |
| PE Ratio (ttm) | -3.12 |
| Forward PE | -4.5 |
| Analyst | n/a |
| Ask | 3.7 |
| Volume | 7,254 |
| Avg. Volume (20D) | 94,747 |
| Open | 3.65 |
| Previous Close | 3.63 |
| Day's Range | 3.62 - 3.68 |
| 52-Week Range | 2.03 - 6.48 |
| Beta | 0.81 |
About NVNO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVNO
Website n/a
7 months ago
-28%
EnVVeno Medical shares are trading lower after the...
Unlock content with
Pro Subscription
7 months ago
-1.75%
EnVVeno Medical shares are trading lower after the company announced a proposed public offering.
2 weeks ago · accessnewswire.com
VenoValve to be Featured During Presentation at the 47th Annual Charing Cross SymposiumIRVINE, CA / ACCESS Newswire / April 23, 2025 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease...
3 weeks ago · accessnewswire.com
enVVeno Medical to Participate in a Live Virtual Investor Closing Bell SegmentModerated webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Tuesday, April 22nd at 4:00 PM ET IRVINE, CA / ACCESS Newswire / April 16, 2025 / enVVeno Medical Corporation (Nasda...
2 months ago · accessnewswire.com
enVVeno Medical Participates in the Virtual Investor “Top 5 for ‘25” On-Demand ConferenceOn-demand video webcast now available here IRVINE, CA / ACCESS Newswire / February 19, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of...
